|
Volumn 33, Issue 6, 2012, Pages 2209-2216
|
Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA BINDING PROTEIN;
ENDONUCLEASE;
ERCC1 PROTEIN, HUMAN;
TUMOR MARKER;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CHINA;
CLINICAL TRIAL;
ENZYME IMMUNOASSAY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
LYMPH NODE METASTASIS;
MALE;
METABOLISM;
METASTASIS;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
PROGNOSIS;
RETROSPECTIVE STUDY;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
ADENOCARCINOMA;
ADULT;
AGED;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
CHINA;
DNA-BINDING PROTEINS;
ENDONUCLEASES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOENZYME TECHNIQUES;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 85027958439
PISSN: None
EISSN: 14230380
Source Type: Journal
DOI: 10.1007/s13277-012-0482-4 Document Type: Article |
Times cited : (7)
|
References (0)
|